Skip to Content

Institutional Biosafety Committee

Robert McLean, Regents Professor, Biology, Co-Chair (R)
Hong Gu Kang, Associate Professor, Biology, Co-Chair (R)

Nihal Dharmasiri, Associate Professor, Biology (R)
Monty Gomez, Non-institutional Member (R)
Brigid Lednicky, Non-institutional Member (R)
Kevin Lewis, Professor, Chemistry and Biochemistry (R)
Rodney Rohde, Program Chair, Professor, Clinical Laboratory Science, Associate Dean of Research, Health Professions (R)
Alissa Savage, Scientific Instrument Technician, Shared Research Operations (R)

Ex Officio:
Michael Blanda, Assistant Vice President, Research and Federal Relations (T)
Elsie Romano, Environmental Health and Safety Specialist, Environmental, Health, Safety, Risk and Emergency Management (T)

Institutional Biosafety Committees (IBCs) were established under the NIH Guidelines for Research Involving Recombinant DNA Molecules to provide local review and oversight of nearly all forms of research utilizing recombinant DNA. The Texas State IBC also reviews a variety of experimentation that involves biological materials (e.g., infectious agents).